By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is that selling puts on CRDO at the current high implied volatility is risky, with potential for significant losses if the stock gaps down due to negative catalysts or a shift in AI capex priorities by major customers. The high premiums offered by these 'YieldBoost' strategies do not compensate for the elevated risk.
Risk: Elevated implied volatility and potential gap moves due to negative catalysts or shifts in hyperscaler CAPEX priorities
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The put contract at the $250.00 strike price has a current bid of $64.30. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $250.00, but will also collect the premium, putting the cost basis of the shares at $185.70 (before broker commissions). To an investor already interested in purchasing shares of CRDO, that could represent an attractive alternative to paying $257.39/share today.
Because the $250.00 strike represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 68%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 25.72% return on the cash commitment, or 53.63% annualized — at Stock Options Channel we call this the *YieldBoost*.
Below is a chart showing the trailing twelve month trading history for Credo Technology Group Holding Ltd, and highlighting in green where the $250.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $280.00 strike price has a current bid of $68.00. If an investor was to purchase shares of CRDO stock at the current price level of $257.39/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $280.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 35.20% if the stock gets called away at the December 18th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CRDO shares really soar, which is why looking at the trailing twelve month trading history for Credo Technology Group Holding Ltd, as well as studying the business fundamentals becomes important. Below is a chart showing CRDO's trailing twelve month trading history, with the $280.00 strike highlighted in red:
Considering the fact that the $280.00 strike represents an approximate 9% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 38%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 26.42% boost of extra return to the investor, or 55.09% annualized, which we refer to as the *YieldBoost*.
The implied volatility in the put contract example is 110%, while the implied volatility in the call contract example is 108%.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 251 trading day closing values as well as today's price of $257.39) to be 87%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
### Further CRDO Research:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Yield-focused option selling on CRDO can look attractive, but the apparent risk-adjusted returns hinge on stability or upside in a volatile stock, and ignore real-world costs and potential catalysts that could dramatically alter outcomes."
CRDO's December 18 option setup offers high-implied-vol premium plays: a short 250 put and a covered 280 call, with YieldBoosts cited around 25%–56% annualized. The strongest caveat is that those payouts rely on outsized IV and a relatively narrow price path; a negative catalyst or a sizable gap-down could erase premium gains and force a sizable loss on the put assignment (cost basis effectively ~185.70 if exercised at 250 while the stock trades lower). Real-world friction also matters: commissions, taxes, bid-ask spreads, and the risk of early exercise; margins if unhedged. Without fundamental conviction on CRDO’s earnings/growth, these look like riskful income plays rather than a strategic edge.
If CRDO delivers a bullish catalyst or surprise earnings, selling puts and writing covered calls can outperform outright stock ownership by harvesting premium while still participating on upside; the downside risk is real, but the upside protection is limited only by the calls’ strike and potential roll opportunities.
"The high option premiums reflect a market pricing in extreme binary risk, making yield-harvesting strategies dangerous for investors who aren't prepared for a significant drawdown."
Credo Technology (CRDO) is currently trading at a premium valuation, reflecting aggressive growth expectations in data center connectivity. The article’s focus on 'YieldBoost' strategies—selling puts at $250 or covered calls at $280—masks the underlying risk of extreme implied volatility (108-110%). With actual trailing volatility at 87%, these premiums are high for a reason: the market is pricing in massive potential for a gap move. Investors selling these options are essentially harvesting volatility, but they are exposed to significant downside if the AI infrastructure cycle hits a demand hiccup or if the company misses on margin expansion in their next earnings print.
The strongest case against this caution is that CRDO is a high-beta play on AI infrastructure; if hyperscalers continue to ramp CAPEX, the stock's momentum could easily outpace the premium, making the 'capped upside' of a covered call a poor strategy compared to simply holding the equity.
"The article treats option premiums as free money without investigating why IV is 23 points above realized volatility — a red flag for undisclosed event risk."
This article is a mechanics tutorial masquerading as investment advice. CRDO is trading at $257.39 with 110% implied volatility on puts and 108% on calls — both well above the 87% realized vol. That spread suggests the market is pricing in binary event risk the article never mentions. The 'YieldBoost' math is correct but misleading: 53.63% annualized assumes you repeat this weekly for a year without a gap move. The real question isn't whether the put expires worthless (68% prob) — it's why IV is so elevated. Is CRDO facing earnings, FDA approval, or competitive pressure? The article omits this entirely. Selling a $250 put at $64.30 premium looks attractive until the stock drops 20% on bad guidance.
If CRDO is a legitimate growth story with healthy fundamentals and the elevated IV reflects sector-wide semiconductor volatility rather than company-specific risk, then the premium is genuinely fat and this is a rational income play for patient capital.
"CRDO options are pricing volatility well above trailing realized levels, so the advertised yields may not compensate for tail-move risk the article downplays."
The article frames CRDO's December 18 $250 put and $280 call as high-yield opportunities (53-55% annualized YieldBoost) with 68% and 38% probabilities of expiring worthless. This rests on implied volatility of 108-110% versus 87% trailing realized volatility, implying the market expects outsized moves. For income-focused investors the premiums look attractive relative to the 3-9% OTM distances, yet the gap between IV and historical vol signals potential event risk or mean-reversion that could erase those yields quickly. The piece provides no fundamental context on Credo’s earnings trajectory or sector exposure.
If a single catalyst (earnings, customer news, or sector rotation) drives a 20%+ move before expiration, the reported probabilities collapse and the strategies suffer losses far larger than the collected premiums.
"Weekly short puts carry gamma and assignment risk that can wipe out premium gains, especially with liquidity and rolling costs ignored."
Grok raises the point that one catalyst can collapse those win probabilities, but the real flaw is gamma and assignment risk in a weekly short-put strategy. If CRDO sits around 257, the 250 put gets highly delta-sensitive; a bad earnings cue or guidance miss can trigger immediate assignment, forcing an cost basis of 250 minus premium rather than a clean premium harvest. The article underplays liquidity frictions and rolling costs that erode returns over multiple cycles.
"Selling CRDO puts is a proxy bet on sustained hyperscaler CAPEX, which carries significant, unpriced concentration risk."
Claude is right to flag the IV-realized vol spread, but everyone is missing the elephant in the room: the semiconductor supply chain. CRDO is a high-beta play on AI infrastructure, yet we are ignoring the concentration risk of its hyperscaler customers. If a major client like Microsoft or Amazon shifts CAPEX priorities, the stock won't just 'gap down'—it will crater. Selling puts here isn't just harvesting volatility; it's effectively selling insurance on the entire AI capex cycle.
"Customer concentration risk is priced into IV; margin compression risk is not, and it's the real tail risk for put sellers."
Gemini's customer concentration risk is real, but it's priced into that 110% IV—not hidden. The actual gap nobody's closing: CRDO's gross margin trajectory. If AI capex holds but CRDO's mix shifts toward lower-margin products (common in commodity connectivity), the stock craters even without a demand cliff. The put seller takes that hit. Article ignores margin guidance entirely.
"Customer concentration and margin-mix shifts compound each other, amplifying downside for CRDO put sellers beyond what IV alone prices."
Gemini and Claude overlook the direct link between hyperscaler concentration and margin compression: when Microsoft or Amazon demands standardized lower-margin connectivity to scale AI clusters, CRDO's product mix shifts exactly as volumes rise. That interaction isn't isolated in the 110% IV and would trigger assignment losses on the $250 put well before any broad demand cliff materializes.
The panel consensus is that selling puts on CRDO at the current high implied volatility is risky, with potential for significant losses if the stock gaps down due to negative catalysts or a shift in AI capex priorities by major customers. The high premiums offered by these 'YieldBoost' strategies do not compensate for the elevated risk.
None identified
Elevated implied volatility and potential gap moves due to negative catalysts or shifts in hyperscaler CAPEX priorities